Player FMアプリでオフラインにしPlayer FMう!
Key Decisions in HIV Care: Switching to Long-Acting ART
Manage episode 296936278 series 2884624
In this episode, Daniel J. Kuritzkes, MD, reviews key clinical trial data and gives practical insights such as how to initiate a patient on long-acting therapy, recommended dosing regimens, and factors that may increase the risk of treatment failure. The overview will include analyses of:
- ATLAS and FLAIR studies of long-acting injectable CAB + RPV
- ATLAS 2M dosing study
- FDA approval and DHHS statement on use of long-acting injectable ART
- Studies on whether an oral lead-in is needed
Presenter:
Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Follow along with the slides at:
https://bit.ly/3hNfHII
See the entire program at:
https://bit.ly/2TXTYWx
378 つのエピソード
Manage episode 296936278 series 2884624
In this episode, Daniel J. Kuritzkes, MD, reviews key clinical trial data and gives practical insights such as how to initiate a patient on long-acting therapy, recommended dosing regimens, and factors that may increase the risk of treatment failure. The overview will include analyses of:
- ATLAS and FLAIR studies of long-acting injectable CAB + RPV
- ATLAS 2M dosing study
- FDA approval and DHHS statement on use of long-acting injectable ART
- Studies on whether an oral lead-in is needed
Presenter:
Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Follow along with the slides at:
https://bit.ly/3hNfHII
See the entire program at:
https://bit.ly/2TXTYWx
378 つのエピソード
すべてのエピソード
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。